Authors
Latest:
Sex-related differences in treatment and outcome in patients with ACSThe AMIS (Acute Myocardial Infarction in Switzerland) Plus prospective cohort study compared treatment and in-hospital outcomes between men and women with acute coronary syndrome (N = 26,452) admitted to Swiss hospitals between 1997 and 2007. The study reached several important conclusions: women had different baseline characteristics than men at admission, were treated with different drug regimens, and were significantly less likely to undergo percutaneous coronary intervention. After adjusting for these differences, researchers found no significant difference in the rates of in-hospital mortality between men and women, except for women aged 51 to 60 years, who were more likely to die in-hospital.
Latest:
Vodou Baby--the Birth of a SurgeonA Haitian nurse offered advice: "Keep your textbook nearby".
Latest:
What is the Most Effective Treatment Strategy for Patients with Secondary Progressive Multiple Sclerosis?Experts examine conflicting evidence regarding the continuation of disease-modifying therapy in patients with secondary progressive multiple sclerosis.
Latest:
2018-2019 Flu Vaccine Recommendations from ACIPNew recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.
Latest:
Medication-Free Strategies Can Prevent Coronary Heart DiseaseDrug therapy is recognized as an effective way to lower lipids and control hypertension, and for its effect on reducing the incidence of myocardial infarction. However, the impact of personal habits, such as eating, drinking, smoking, and exercise, on the incidence of coronary heart disease without reliance on prescription medications and their potential side effects may be less well established.
Latest:
National Strategy to Reduce Prescription Drug AbusePsychiatrist Steven Roy Daviss, MD provides a detailed review of the elements in the National Drug Control Strategy.
Latest:
Early Momentum for a Genomic Approach to Sickle Cell Disease TherapyIn a late-breaking presentation at ASGCT 2022, investigators shared preclinical results of a gene-editing strategy that seeks to reactivate developmentally silenced fetal hemoglobin (HbF, α2γ2) in order to replace defective sickle hemoglobin (HbS, α2βS2).
Latest:
Interoperability and Standards: The Effect on Patient CareAs clinicians, we are increasingly accustomed to using EMRs in the hospital, as well as practice management and billing systems in the office.
Latest:
BRAF Mutation Emerging as Prognostic in KRAS Wild-Type CRC PatientsColorectal cancer patients who had wild-type (normal) KRAS gene status, but mutations in the BRAF, had a poor prognosis in spite of treatment with cetuximab.
Latest:
Get Connected with Online Physician ConsultationsHow does today’s connected, "always on" world translate to your medical practice?
Latest:
CV Risk in Rheumatic Disease(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.
Latest:
ADHD Continues to Rise in ChildrenFrom 2010 to 2017, there was an increase of over 30% in the number of commercially insured children being diagnosed with ADHD.
Latest:
In Treatment: Jesse. Adele. Week 2.What happened in the latest episode of HBO's In Treatment, and how does it apply to real-life therapy?
Latest:
How Should I Manage This Man's Pustulovesicular Rash?A 61 year old male is seen by you for a 3 day history of progressive burning and tingling in the right mid-back area. He reports this morning his wife reports the development of a rash in the area of his symptoms. Examination reveals several grouped pustulovesicular lesions in a right T10 distribution. He denies ever having chickenpox as a child.
Latest:
Insulin resistance and heart failureThe prevalence of obesity and heart failure has been increasing. A report linking the 2 found an increased risk of heart failure of 5% for men and 7% for women for each increment of 1 in body mass index (BMI).
